Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
139.13%
0%
139.13%
6 Months
116.01%
0%
116.01%
1 Year
101.13%
0%
101.13%
2 Years
-16.13%
0%
-16.13%
3 Years
-12.27%
0%
-12.27%
4 Years
-71.68%
0%
-71.68%
5 Years
-79.79%
0%
-79.79%
Valerio Therapeutics SA for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-12.99%
EBIT Growth (5y)
0.00%
EBIT to Interest (avg)
-12.23
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
2.24
Sales to Capital Employed (avg)
0.12
Tax Ratio
10.47%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-1.01
EV to EBIT
-1.21
EV to EBITDA
-1.49
EV to Capital Employed
6.75
EV to Sales
11.75
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-558.57%
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
Bearish
Bollinger Bands
Sideways
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
No Trend
Shareholding Snapshot : Jun 2023
Shareholding Compare (%holding) 
Majority shareholders
Non Institution
Domestic Funds
Held in 1 Schemes (0.01%)
Foreign Institutions
Held by 4 Foreign Institutions (26.93%)
Strategic Entities with highest holding
Highest Public shareholder
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
1.80
1.40
28.57%
Operating Profit (PBDIT) excl Other Income
-20.90
-18.60
-12.37%
Interest
0.20
2.20
-90.91%
Exceptional Items
0.00
-0.20
100.00%
Consolidate Net Profit
-20.30
-19.60
-3.57%
Operating Profit Margin (Excl OI)
-11,900.00%
-12,880.80%
98.08%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is 28.57% vs -65.85% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is -3.57% vs -232.20% in Dec 2022
About Valerio Therapeutics SA 
Valerio Therapeutics SA
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






